KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Eli Lilly's Tax Provisions rose 16693.09% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 billion, marking a year-over-year increase of 12978.21%. This contributed to the annual value of $2.1 billion for FY2024, which is 5906.25% up from last year.
  • According to the latest figures from Q3 2025, Eli Lilly's Tax Provisions is $1.6 billion, which was up 16693.09% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Tax Provisions registered a high of $1.6 billion during Q3 2025, and its lowest value of $113.8 million during Q4 2021.
  • In the last 5 years, Eli Lilly's Tax Provisions had a median value of $293.2 million in 2024 and averaged $421.2 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 6769.8% in 2021, then soared by 32583.48% in 2023.
  • Quarter analysis of 5 years shows Eli Lilly's Tax Provisions stood at $113.8 million in 2021, then surged by 39.46% to $158.7 million in 2022, then soared by 101.07% to $319.1 million in 2023, then soared by 97.09% to $628.9 million in 2024, then soared by 162.35% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.1 billion for Q2 2025, and $696.8 million during Q1 2025.